ClinicalTrials.gg
Active, not recruitingNCT06254222Updated Feb 12, 2024

Ethical Crossroads in Nursing Education

An observational study in Ethics, Narrative and Professional Identity Formation, sponsored by Mansoura University. Active, not recruiting at 1 site in Egypt. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-02-12.

Sponsored by Mansoura University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 7 months ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
224
Ages
18 Years to 25 Years
Sex
All
01

Study summary

In conclusion, understanding the variables influencing ethical decision-making among nursing students is crucial for developing interventions to minimize moral distress and promoting their ability to cope with ethical issues and dilemmas. While acknowledging the existence of ethical challenges, it is noteworthy that there is a dearth of studies investigating the intricate relationship between ethical sensitivity and the development of professional identity among nursing students. This research aims to fill this gap, advancing our understanding and providing valuable insights for shaping effective educational practices. In this improvement, the research problem is clearly stated: the need to explore the relationship between ethical sensitivity and professional identity among nursing students, with a call for further research to bridge the existing gap.

In light of the identified research gap regarding the correlation between ethical sensitivity and the development of professional identity among nursing students, this study seeks to answer the following question: How does ethical sensitivity influence the formation of professional identity in nursing students within the context of contemporary healthcare environments, characterized by evolving technology and complex health systems?

02

Conditions studied

  • Ethics, Narrative
  • Professional Identity Formation

Browse trials for

03

In context

Narration

39 studies on the registry are indexed under Narration; 3 are open to participants now.

This study's planned enrollment of 224 is above the median of 162 across 10 observational studies indexed under Narration.

Browse Narration studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,121 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Nursing students from all levels

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants will be recruited from diverse online communities, including platforms such as Facebook, WhatsApp, and Telegram. The decision to utilize these social media channels is based on their extensive usage within the target population, ensuring effective outreach and active participation. The undergraduate nursing students at the college are expected to establish dedicated social media groups for each academic level.

Exclusion criteria

Exclusion Criteria:

  • Students not from nursing background education
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
224 participants (estimated)
Patient registry
No

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Moral Sensitivity Questionnaire

    This version was modified by Comrie (2012) to measure the moral sensitivity of student nurses (MMSQSN). According to Comrie, determining the level of ethical sensitivity of student nurses can identify what nursing education programs should do to develop ethical sensitivity. Comrie studied the validity and reliability of the MMSQSN using 250 undergraduate and postgraduate student nurses at a midwestern university. Cronbach's alpha was .64. The MMSQSN is a 7-point Likert type scale that includes 30 items. Statements in the scale are assigned a score between 1 (I completely disagree) and 7 (I completely agree).

    Time frame: through study completion, an average of 6 months

Secondary outcomes

  1. Professional Identity Questionnaire

    This instrument contains 17 items loading on 5 sub-dimensions: professional self-image (6 items), retention benefit and risk of turnover (4 items), social comparison and self-reflection (3 items), career choice independence (2 items) and social modelling (2 items). Items are assessed on a five-point Likert scale ('complete conformity' = 5, 'conformity' = 4, 'neutral' = 3, 'inconformity' = 2, and 'complete inconformity' = 1). The total scores range from 17 to 85, with higher scores indicating a stronger professional identity

    Time frame: through study completion, an average of 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2024 (actual). Primary completion is estimated for Apr 2024, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2024
First posted
Feb 12, 2024
StartActual
Feb 1, 2024
Primary completionEst.
Apr 10, 2024
CompletionEst.
Jun 1, 2024
Last update
Feb 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06254222
Responsible party
Ahmed Hashem El-Monshed (Associate Professor, Mansoura University) — Principal investigator
First posted
Feb 12, 2024
Start date
Feb 1, 2024
Primary completion
Apr 10, 2024 (estimated)
Completion
Jun 1, 2024 (estimated)
Last update
Feb 12, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion